950 Final analysis: phase 1b study investigating intratumoral injection of toll-like receptor 9 agonist vidutolimod ± pembrolizumab in patients with PD-1 blockade–refractory melanoma

• Hong Liu,
• Kim Margolin,
• Antoni Ribas,
• Adil Daud,
• Mohammed Milhem,
• Elizabeth Buchbinder,
• Geoffrey Gibney,
• Jason Luke,
• Diwakar Davar,
• Takami Sato,
• Bartosz Chmielowski,
• Luping Zhao,
• Yousef Zakharia,
• Theresa Medina,
• John Kirkwood,
• Jiaxin Niu,
• Anthony Olszanski,
• Montaser Shaheen,
• George Weiner,
• Arthur Krieg,
• Inderjit Mehmi,
• Heather Kelley,
• James Wooldridge,
• Dmitri Bobilev

Affiliations

Hong Liu

Teaching and Research Office of Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China

Kim Margolin

Medical Oncology, City of Hope National Medical Center and Comprehensive Cancer Center, Duarte, California, USA

Antoni Ribas

3 Division of Hematology-Oncology, Jonsson Comprehensive Cancer Center, Department of Medicine, University of California at Los Angeles, Los Angeles, California, USA

Adil Daud

University of California San Francisco, San Francisco, California, USA

Mohammed Milhem

The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA

Elizabeth Buchbinder

3Dana Farber Cancer Institute, Boston, MA, USA

Geoffrey Gibney

8Georgetown University, Washington, DC, USA

Jason Luke

1University of Iowa, Iowa City, IA, USA

Diwakar Davar

1University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Takami Sato

Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA

Bartosz Chmielowski

Aff10 grid.19006.3e0000000096326718Division of Hematology - Medical OncologyUCLA Jonsson Comprehensive Cancer Center Los Angeles CA USA

Luping Zhao

Aff8 grid.418152.bAstraZeneca Gaithersburg MD USA

Yousef Zakharia

University of Iowa Holden Comprehensive Cancer Center, Iowa City, Iowa, USA

Theresa Medina

5University of Colorado, Aurora, CO, USA

John Kirkwood

16University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Jiaxin Niu

7Banner MD Anderson Cancer Center, Gilbert, AZ, USA

Anthony Olszanski

4Fox Chase Cancer Center, Philadelphia, PA, USA

Montaser Shaheen

7University of Arizona, Pheonix, AZ, USA

George Weiner

1University of Iowa, Iowa City, IA, USA

Arthur Krieg

1Checkmate Pharmaceuticals, Cambridge, MA, USA

Inderjit Mehmi

11The Angeles Clinic and Research Institut, Los Angeles, CA, USA

Heather Kelley

14Checkmate Pharmaceuticals Inc., Cambridge, MA, USA

James Wooldridge

14Checkmate Pharmaceuticals Inc., Cambridge, MA, USA

Dmitri Bobilev

14Checkmate Pharmaceuticals Inc., Cambridge, MA, USA